Teladoc Health (TDOC) Stock Price, News & Analysis

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TDOC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TDOC, but not buy additional shares or sell existing shares.
View TDOC analyst ratings or view top-rated stocks.

13 Wall Street analysts have issued 12 month price targets for Teladoc Health's stock. Their TDOC share price targets range from $17.00 to $29.00. On average, they expect the company's stock price to reach $22.23 in the next twelve months. This suggests a possible upside of 66.6% from the stock's current price.
View analysts price targets for TDOC or view top-rated stocks among Wall Street analysts.

Teladoc Health's stock was trading at $21.55 at the beginning of the year. Since then, TDOC stock has decreased by 38.1% and is now trading at $13.34.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our TDOC earnings forecast.

Teladoc Health will be holding an earnings conference call on Thursday, April 25th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

Teladoc Health, Inc. (NYSE:TDOC) posted its quarterly earnings results on Tuesday, February, 20th. The health services provider reported ($0.17) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.22) by $0.05. The health services provider earned $660.50 million during the quarter, compared to analyst estimates of $670.79 million. Teladoc Health had a negative net margin of 8.47% and a negative trailing twelve-month return on equity of 9.22%. The firm's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.23) EPS.

ETFs with the largest weight of Teladoc Health (NYSE:TDOC) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), ARK Genomic Revolution ETF (ARKG), ARK Next Generation Internation ETF (ARKW), ARK Fintech Innovation ETF (ARKF), Fidelity Digital Health ETF (FDHT), ARK Innovation ETF (ARKK), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares Virtual Work and Life Multisector ETF (IWFH).

Teladoc Health issued an update on its first quarter 2024 earnings guidance on Wednesday, April, 10th. The company provided earnings per share guidance of -0.550--0.450 for the period, compared to the consensus earnings per share estimate of -0.460. The company issued revenue guidance of $630.0 million-$645.0 million, compared to the consensus revenue estimate of $637.4 million.

106 employees have rated Teladoc Health Chief Executive Officer Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among the company's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Block (SQ), Shopify (SHOP), DocuSign (DOCU), Salesforce (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

Teladoc Health (TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health's stock is owned by many different institutional and retail investors. Top institutional investors include IMC Chicago LLC (0.00%), Banque Cantonale Vaudoise (0.06%), Counterpoint Mutual Funds LLC (0.01%), Ignite Planners LLC (0.01%) and Avondale Wealth Management (0.00%). Insiders that own company stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Claus Torp Jensen, Daniel Trencher, David Travers, David William Sides, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Laizer Kornwasser, Mala Murthy, Michael Willem Waters, Nikolaos P Nanis, Richard J Napolitano, Sandra L Fenwick, Stephany Verstraete and Vidya Raman-Tangella.
View institutional ownership trends.

Shares of TDOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.